Marco Zarbin

Summary

Country: USA

Publications

  1. doi request reprint Cell-Based Therapy for Degenerative Retinal Disease
    Marco Zarbin
    Rutgers New Jersey Medical School, Newark, NJ 07103, USA Electronic address
    Trends Mol Med 22:115-34. 2016
  2. doi request reprint Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis
    Marco A Zarbin
    Institute of Ophthalmology and Visual Science, New Jersey Medical School, Newark, New Jersey 07103, USA
    Ophthalmology 120:1432-9. 2013

Research Grants

Detail Information

Publications2

  1. doi request reprint Cell-Based Therapy for Degenerative Retinal Disease
    Marco Zarbin
    Rutgers New Jersey Medical School, Newark, NJ 07103, USA Electronic address
    Trends Mol Med 22:115-34. 2016
    ..A greater understanding of the mechanisms controlling synapse formation as well as the immunoreactivity of transplanted retinal cells is urgently needed. ..
  2. doi request reprint Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis
    Marco A Zarbin
    Institute of Ophthalmology and Visual Science, New Jersey Medical School, Newark, New Jersey 07103, USA
    Ophthalmology 120:1432-9. 2013
    ..To report outcomes of ophthalmic evaluations in clinical studies of patients receiving fingolimod (Gilenya; Novartis Pharma AG, Basel, Switzerland) for multiple sclerosis (MS)...

Research Grants2

  1. PIGMENT EPITHELIUM REMOVAL AND TRANSPLANTATION
    Marco Zarbin; Fiscal Year: 2003
    ..IV: Assess long-term viability of syngeneic RPE sheet transplants onto damaged Bruch's membrane using a published in vivo RPE debridement model. ..
  2. Enhancing Cell Survival on Aged Bruch's Membrane
    Marco Zarbin; Fiscal Year: 2007
    ..abstract_text> ..